Meropenem Supplier-Buyer Network — Trade Flow Analysis

Name: Meropenem Supplier-Buyer Trade Network Dataset — 401+ Indian Exporters, 22+ Importers, 134+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Meropenem supplier network, Meropenem buyers, pharmaceutical export India, Meropenem trade data

TransData Nexus

Meropenem

India Pharmaceutical Trade Intelligence

$222.9M401 Suppliers134 CountriesHS 30049099

ExportsIndia → BELGIUM32.0%India → UNITED STATES15.5%

ImportsSWITZERLAND → India$418.3M BELGIUM → India$257.7K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Who Supplies Meropenem? Top Manufacturers & Buyers 2026 — SUN PHARMACEUTICAL INDUSTRIES LIMITED Leads | TransData Nexus | TransData Nexus

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Meropenem exporter from India, with a market share of 36.0% and a total export value of $80.2M across 206 shipments. Their average shipment value of $389.5K is above the market average of $60.9K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 78.8% of this supplier's tracked business. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $63.2M across 162 shipments (78.8% of this supplier's total exports)

• M/S. SUN PHARMA ANZ PTY LTD — $15.4M across 39 shipments (19.2% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $958.5K across 2 shipments (1.2% of this supplier's total exports)

• M S SANKIL PHARMACEU — $348.7K across 1 shipments (0.4% of this supplier's total exports)

• RANBAXY PHARMACEUTIC — $313.5K across 1 shipments (0.4% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $389.5K is 539% above the market average of $60.9K, consistent with large-order contracts or value-added formulations.

2EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Meropenem exporter from India, with a market share of 9.8% and a total export value of $21.8M across 341 shipments. Their average shipment value of $64.0K is above the market average of $60.9K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. EUGIA US LLC, is the dominant customer, accounting for 53.3% of this supplier's tracked business. Top customers include:

• EUGIA US LLC, — $11.6M across 182 shipments (53.3% of this supplier's total exports)

• EUGIA US LLC, — $7.7M across 120 shipments (35.1% of this supplier's total exports)

• AUROVIDA FARMACEUTIC — $1.2M across 18 shipments (5.4% of this supplier's total exports)

• AUROBINDO PHARMA COL — $783.3K across 12 shipments (3.6% of this supplier's total exports)

• EUGIA PHARMA INDUSTR — $567.1K across 9 shipments (2.6% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $64.0K is 5% above the market average of $60.9K, consistent with large-order contracts or value-added formulations.

3VENUS REMEDIES LIMITED

VENUS REMEDIES LIMITED is the third-largest Meropenem exporter from India, with a market share of 6.4% and a total export value of $14.3M across 801 shipments. Their average shipment value of $17.9K is below the market average of $60.9K, reflecting a high-volume, competitive pricing strategy.

VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• S T C — $4.4M across 246 shipments (30.7% of this supplier's total exports)

• E P H K — $3.6M across 202 shipments (25.2% of this supplier's total exports)

• VENUS PHARMA GMBH — $3.2M across 178 shipments (22.2% of this supplier's total exports)

• G H — $1.7M across 96 shipments (12.0% of this supplier's total exports)

• S T C SALEHIYA TRADING — $1.4M across 79 shipments (9.9% of this supplier's total exports)

Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (801 shipments) at a per-shipment value of $17.9K, indicating a broad distribution network with many smaller, regular orders.

4BROOKS STERISCIENCE LIMITED

BROOKS STERISCIENCE LIMITED is the fourth-largest Meropenem exporter from India, with a market share of 1.2% and a total export value of $2.6M across 45 shipments. Their average shipment value of $57.9K is below the market average of $60.9K, reflecting a high-volume, competitive pricing strategy.

BROOKS STERISCIENCE LIMITED serves 5 named buyers in our database. ARMAS PHARMACEUTICALS is the dominant customer, accounting for 74.1% of this supplier's tracked business. Top customers include:

• ARMAS PHARMACEUTICALS — $1.9M across 33 shipments (74.1% of this supplier's total exports)

• CARDINAL 3PL — $373.8K across 6 shipments (14.4% of this supplier's total exports)

• AMIPHARMA LABORATORI — $182.2K across 3 shipments (7.0% of this supplier's total exports)

• TO THE ORDER OF — $84.2K across 1 shipments (3.2% of this supplier's total exports)

• SANIMED PHARMACEUTIC — $33.7K across 1 shipments (1.3% of this supplier's total exports)

Key Insight: BROOKS STERISCIENCE LIMITED operates with high shipment frequency (45 shipments) at a per-shipment value of $57.9K, indicating a broad distribution network with many smaller, regular orders.

5VENUS REMEDIES LTD

VENUS REMEDIES LTD is the fifth-largest Meropenem exporter from India, with a market share of 1.0% and a total export value of $2.2M across 33 shipments. Their average shipment value of $67.3K is above the market average of $60.9K, suggesting premium or bulk contract pricing.

VENUS REMEDIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• S T C SALEHIYA TRADING — $1.0M across 16 shipments (47.2% of this supplier's total exports)

• VPG VENUS PHARMA GMBHAM BAHNHOF — $930.5K across 14 shipments (41.9% of this supplier's total exports)

• O S A C M S OQCORP S — $135.4K across 2 shipments (6.1% of this supplier's total exports)

• M P L M S MEDICAL PR — $57.1K across 1 shipments (2.6% of this supplier's total exports)

• PDT S A PROLIFE DE — $50.9K across 1 shipments (2.3% of this supplier's total exports)

Key Insight: VENUS REMEDIES LTD's per-shipment value of $67.3K is 11% above the market average of $60.9K, consistent with large-order contracts or value-added formulations.

6GUFIC BIOSCIENCES LIMITED

GUFIC BIOSCIENCES LIMITED is the fifth-largest Meropenem exporter from India, with a market share of 0.2% and a total export value of $400.0K across 15 shipments. Their average shipment value of $26.7K is below the market average of $60.9K, reflecting a high-volume, competitive pricing strategy.

GUFIC BIOSCIENCES LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER OF — $200.0K across 7 shipments (50.0% of this supplier's total exports)

• NA — $200.0K across 7 shipments (50.0% of this supplier's total exports)

• SLIM PHARMACEUTICALS — $48 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: GUFIC BIOSCIENCES LIMITED operates with high shipment frequency (15 shipments) at a per-shipment value of $26.7K, indicating a broad distribution network with many smaller, regular orders.

1Belgium

Belgium ranks as the first-largest destination for Meropenem imports from India, with a total trade value of $71.4M across 143 shipments — representing a 32.0% share of all Meropenem exports. The average shipment value of $499.2K is above the global average of $60.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Meropenem importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 97.8% ($69.8M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $69.8M (97.8% of Belgium's total)

Key Insight: Belgium's per-shipment average of $499.2K (719% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Meropenem imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Meropenem imports from India, with a total trade value of $34.6M across 230 shipments — representing a 15.5% share of all Meropenem exports. The average shipment value of $150.2K is above the global average of $60.9K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.

Named Meropenem importers in United States: EUGIA US LLC, is the largest buyer, accounting for 39.9% ($13.8M) of this market's total imports.

• EUGIA US LLC, — $13.8M (39.9% of United States's total)

• EUGIA US LLC — $7.7M (22.2% of United States's total)

• AUROMEDICS PHARMA, LLC, — $5.6M (16.2% of United States's total)

Key Insight: United States's per-shipment average of $150.2K (147% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Meropenem imports from India.

Primary Market

Secondary Market

3Australia

Australia ranks as the third-largest destination for Meropenem imports from India, with a total trade value of $19.4M across 7 shipments — representing a 8.7% share of all Meropenem exports. The average shipment value of $2.8M is above the global average of $60.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Meropenem importers in Australia: M/S. SUN PHARMA ANZ PTY LTD is the largest buyer, accounting for 80.1% ($15.5M) of this market's total imports.

• M/S. SUN PHARMA ANZ PTY LTD — $15.5M (80.1% of Australia's total)

Key Insight: Australia's per-shipment average of $2.8M (4445% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Meropenem imports from India.

Primary Market

Secondary Market

4Germany

Germany ranks as the fourth-largest destination for Meropenem imports from India, with a total trade value of $13.3M across 159 shipments — representing a 6.0% share of all Meropenem exports. The average shipment value of $83.7K is above the global average of $60.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Meropenem importers in Germany: VENUS PHARMA GMBH is the largest buyer, accounting for 69.9% ($9.3M) of this market's total imports.

• VENUS PHARMA GMBH — $9.3M (69.9% of Germany's total)

• VPG VENUS PHARMA GMBHAM BAHNHOF — $2.2M (16.8% of Germany's total)

Key Insight: Germany's per-shipment average of $83.7K (37% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Meropenem imports from India.

Primary Market

Secondary Market

5Saudi Arabia

Saudi Arabia ranks as the fifth-largest destination for Meropenem imports from India, with a total trade value of $11.0M across 187 shipments — representing a 4.9% share of all Meropenem exports. The average shipment value of $58.9K is below the global average of $60.9K, consistent with generic/API volume purchasing. This market is served by 3 tracked buyers.

Named Meropenem importers in Saudi Arabia: S T C is the largest buyer, accounting for 39.8% ($4.4M) of this market's total imports.

• S T C — $4.4M (39.8% of Saudi Arabia's total)

• SALEHIYA TRADING COMPANY — $3.8M (34.5% of Saudi Arabia's total)

• S T C SALEHIYA TRADING — $2.5M (22.3% of Saudi Arabia's total)

Key Insight: Saudi Arabia receives frequent, smaller shipments of Meropenem — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Saudi Arabia is a key market for Meropenem imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Meropenem.
2.Flow Mapping: 401 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,658 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 134 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,658 Verified Shipments

401 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Meropenem

Meropenem

Who Supplies Meropenem? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Meropenem? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Meropenem Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

2EUGIA PHARMA SPECIALITIES LIMITED

3VENUS REMEDIES LIMITED

4BROOKS STERISCIENCE LIMITED

5VENUS REMEDIES LTD

6GUFIC BIOSCIENCES LIMITED

From Indian Factories to Global Pharmacies — How Meropenem Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Meropenem Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Belgium

2United States

3Australia

4Germany

5Saudi Arabia

People Also Ask — Meropenem Supplier & Trade Network

Meropenem Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology